PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Observational report: Improved outcomes of transscleral cyclophotocoagulation for glaucoma patients.

Abstract The purpose of this article is to evaluate the improved safety and efficacy of transscleral cyclophotocoagulation (TSCPC) by performing it in the operating room.This is a retrospective review of 17 eyes of 16 patients who received TSCPC for uncontrolled glaucoma on maximum tolerated medication.Mean intraocular pressure (IOP) prior to surgery was 30.85 ± 6.24 mm Hg and was reduced to 14.48 ± 3.53 mm Hg after treatment for an average reduction in IOP of 48.56% at the final visit (P < .001). Visual acuity was measured at the final follow-up visit and was stable in 13 eyes (76.47%), improved in 2 eyes (11.75%), and decreased in 2 eyes (11.75%). Nine of the eyes (52.94%) saw a reduction in the number of medications taken, whereas 8 had no change. Two eyes had resolved complications of cystoid macular edema (CME) and subconjunctival hemorrhages. The overall success rate is determined to be 88%.TSCPC performed in the operating room may have greater safety and efficacy for patients with uncontrolled glaucoma.
PMID
Related Publications

Long-term outcome of initial ciliary ablation with contact diode laser transscleral cyclophotocoagulation for severe glaucoma. The Diode Laser Ciliary Ablation Study Group.

Diode laser transscleral cyclophotocoagulation for the treatment of refractory glaucoma after penetrating keratoplasty.

Intraocular pressure control after contact transscleral diode cyclophotocoagulation in eyes with intractable glaucoma.

Diode laser transscleral cyclophotocoagulation as primary surgical treatment for medically uncontrolled chronic angle closure glaucoma: long-term clinical outcomes.

Transscleral diode laser cyclophotocoagulation after baerveldt glaucoma implant surgery.

Authors

Mayor MeshTerms

Laser Coagulation

Keywords
Journal Title medicine
Publication Year Start




PMID- 28591029
OWN - NLM
STAT- MEDLINE
DA  - 20170607
DCOM- 20170706
LR  - 20170706
IS  - 1536-5964 (Electronic)
IS  - 0025-7974 (Linking)
VI  - 96
IP  - 23
DP  - 2017 Jun
TI  - Observational report: Improved outcomes of transscleral cyclophotocoagulation for
      glaucoma patients.
PG  - e6946
LID - 10.1097/MD.0000000000006946 [doi]
AB  - The purpose of this article is to evaluate the improved safety and efficacy of
      transscleral cyclophotocoagulation (TSCPC) by performing it in the operating
      room.This is a retrospective review of 17 eyes of 16 patients who received TSCPC 
      for uncontrolled glaucoma on maximum tolerated medication.Mean intraocular
      pressure (IOP) prior to surgery was 30.85 +/- 6.24 mm Hg and was reduced to 14.48
      +/- 3.53 mm Hg after treatment for an average reduction in IOP of 48.56% at the
      final visit (P &lt; .001). Visual acuity was measured at the final follow-up visit
      and was stable in 13 eyes (76.47%), improved in 2 eyes (11.75%), and decreased in
      2 eyes (11.75%). Nine of the eyes (52.94%) saw a reduction in the number of
      medications taken, whereas 8 had no change. Two eyes had resolved complications
      of cystoid macular edema (CME) and subconjunctival hemorrhages. The overall
      success rate is determined to be 88%.TSCPC performed in the operating room may
      have greater safety and efficacy for patients with uncontrolled glaucoma.
FAU - Bendel, Rick Edward
AU  - Bendel RE
AD  - Mayo Clinic Foundation, Jacksonville, FL.
FAU - Patterson, Michael Ty
AU  - Patterson MT
LA  - eng
PT  - Journal Article
PT  - Observational Study
PL  - United States
TA  - Medicine (Baltimore)
JT  - Medicine
JID - 2985248R
SB  - AIM
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Female
MH  - Follow-Up Studies
MH  - Glaucoma/drug therapy/*surgery
MH  - Humans
MH  - Intraocular Pressure
MH  - *Laser Coagulation/adverse effects
MH  - Male
MH  - Middle Aged
MH  - Retrospective Studies
MH  - Sclera
MH  - Treatment Outcome
MH  - Visual Acuity
PMC - PMC5466207
EDAT- 2017/06/08 06:00
MHDA- 2017/07/07 06:00
CRDT- 2017/06/08 06:00
AID - 10.1097/MD.0000000000006946 [doi]
AID - 00005792-201706090-00005 [pii]
PST - ppublish
SO  - Medicine (Baltimore). 2017 Jun;96(23):e6946. doi: 10.1097/MD.0000000000006946.